相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。SMAD signaling and redox imbalance cooperate to induce prostate cancer cell dormancy
Anh Thu Bui et al.
CELL CYCLE (2015)
Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment
Donna M. Sosnoski et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Mitotic quiescence, but not unique stemness, marks the phenotype of bone metastasis-initiating cells in prostate cancer
Ning Wang et al.
FASEB JOURNAL (2015)
Significance of Apoptotic and Non-apoptotic Disseminated Tumor Cells in the Bone Marrow of Patients With Clinically Localized Prostate Cancer
Tilman Todenhoefer et al.
PROSTATE (2015)
The epigenetic/noncoding origin of tumor dormancy
Francesco Crea et al.
TRENDS IN MOLECULAR MEDICINE (2015)
NR2F1 controls tumour cell dormancy via SOX9-and RAR beta-driven quiescence programmes
Maria Soledad Sosa et al.
NATURE COMMUNICATIONS (2015)
Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy
Nazanin Ruppender et al.
PLOS ONE (2015)
Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells
Takuya Nakamura et al.
ONCOTARGET (2015)
Combined Genome and Transcriptome Analysis of Single Disseminated Cancer Cells from Bone Marrow of Prostate Cancer Patients Reveals Unexpected Transcriptomes
Miodrag Guzvic et al.
CANCER RESEARCH (2014)
Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone
Penelope D. Ottewell et al.
ENDOCRINE-RELATED CANCER (2014)
Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - Results from a large single-centre analysis
Andreas D. Hartkopf et al.
EUROPEAN JOURNAL OF CANCER (2014)
Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells
Lara H. El Touny et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation
Hua Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells
Makiko Ono et al.
SCIENCE SIGNALING (2014)
Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways
Lisly Chery et al.
ONCOTARGET (2014)
Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial
Malgorzata Banys et al.
BMC CANCER (2013)
Single cell transcriptomic analysis of prostate cancer cells
Christopher J. Welty et al.
BMC MOLECULAR BIOLOGY (2013)
Mechanisms Governing Metastatic Dormancy and Reactivation
Filippo G. Giancotti
CELL (2013)
Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma
Tianjiao Lyu et al.
EPIGENETICS (2013)
Disseminated tumor cells and their prognostic significance in nonmetastatic prostate cancer patients
Wolfgang Lilleby et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
Paloma Bragado et al.
NATURE CELL BIOLOGY (2013)
The perivascular niche regulates breast tumour dormancy
Cyrus M. Ghajar et al.
NATURE CELL BIOLOGY (2013)
GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation
Russell S. Taichman et al.
PLOS ONE (2013)
TBK1 Regulates Prostate Cancer Dormancy through mTOR Inhibition
Jin Koo Kim et al.
NEOPLASIA (2013)
Transcriptional changes induced by the tumor dormancy-associated microRNA-190
Nava Almog et al.
TRANSCRIPTION-AUSTIN (2013)
The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites
Hua Gao et al.
CELL (2012)
Staying alive Metabolic adaptations to quiescence
James R. Valcourt et al.
CELL CYCLE (2012)
Notch Signaling Modulates Hypoxia-Induced Neuroendocrine Differentiation of Human Prostate Cancer Cells
Giovanna Danza et al.
MOLECULAR CANCER RESEARCH (2012)
Consensus Micro RNAs Governing the Switch of Dormant Tumors to the Fast-Growing Angiogenic Phenotype
Nava Almog et al.
PLOS ONE (2012)
Gap Junction-Mediated Import of MicroRNA from Bone Marrow Stromal Cells Can Elicit Cell Cycle Quiescence in Breast Cancer Cells
Philip K. Lim et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
Aya Kobayashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Identification of TROP2 (TACSTD2), an EpCAM-Like Molecule, as a Specific Marker for TGF-β1-Dependent Human Epidermal Langerhans Cells
Gregor Eisenwort et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Can We Stop Prostate Specific Antigen Testing 10 Years After Radical Prostatectomy?
Stacy Loeb et al.
JOURNAL OF UROLOGY (2011)
Asymmetric cancer cell division regulated by AKT
Ipsita Dey-Guha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Which Patients With Undetectable PSA Levels 5 Years After Radical Prostatectomy Are Still at Risk of Recurrence?-Implications for a Risk-adapted Follow-up Strategy
Deborah A. Ahove et al.
UROLOGY (2010)
Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence
Todd M. Morgan et al.
CLINICAL CANCER RESEARCH (2009)
Perioperative Activation of Disseminated Tumor Cells in Bone Marrow of Patients With Prostate Cancer
Dorothea Weckermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Small-cell prostate carcinoma: A retrospective analysis of five newly reported cases
Kyle R. Brownback et al.
INDIAN JOURNAL OF UROLOGY (2009)
Prognostic Significance of Disseminated Tumor Cells in the Bone Marrow of Prostate Cancer Patients Treated With Neoadjuvant Hormone Treatment
Jens Koellermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: A comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer
Jesco Pfitzenmaier et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2007)
Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy
Arne Berg et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer
H-F Yuen et al.
HISTOPATHOLOGY (2007)
Dissecting the senescence-like program in tumor cells activated by Ras signaling
Teeru Bihani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Rationale for zoledronic acid therapy in men with hormone-sensitive prostate cancer with or without bone metastasis
F Saad et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2006)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
Molecular staging by RT-PCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer
C Mitsiades et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
Detection and isolation of prostate cancer cells from peripheral blood and bone marrow
WJ Ellis et al.
UROLOGY (2003)
Monoclonal antibody 9C4 recognizes epithelial cellular adhesion molecule, a cell surface antigen expressed in early steps of erythropoiesis
R Lammers et al.
EXPERIMENTAL HEMATOLOGY (2002)
Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer
FJ Bianco et al.
PROSTATE (2001)
Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer:: Detection and prognostic value
D Weckermann et al.
JOURNAL OF UROLOGY (2001)
Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: Continued rise of biochemical failure after 5 years
CL Amling et al.
JOURNAL OF UROLOGY (2000)